1. Percutaneous Biopsy Tract Seeding in a Patient with Muscle-invasive Bladder Cancer
- Author
-
Jennifer Yates, Ahmed Sobieh, Scott Greenberg, Shubha Dave, and Andrew Gusev
- Subjects
medicine.medical_specialty ,Percutaneous ,Urology ,medicine.medical_treatment ,Case Report ,lcsh:RC870-923 ,Percutaneous biopsy ,lcsh:RC254-282 ,Surgical pathology ,Peritoneum ,Biopsy ,Medicine ,Tumor seeding ,Bladder cancer ,medicine.diagnostic_test ,business.industry ,Cystoscopy ,medicine.disease ,lcsh:Diseases of the genitourinary system. Urology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.anatomical_structure ,Upper tract urothelial carcinoma ,Nephrostomy ,Radiology ,business - Abstract
Percutaneous biopsy can be used for tissue diagnosis of bladder tumors when cystoscopy with transurethral resection is not possible. The largest known case series includes 15 patients with no reported complications and good concordance with surgical pathology. However, concern remains regarding exposure of nonurothelial surfaces to tumor cells, as there are rare documented cases of tumor seeding along nephrostomy and biopsy tracts in upper tract urothelial carcinoma (UC). We present the first documented human case of bladder cancer involvement of the omentum and peritoneum along a biopsy tract and review the use of percutaneous access for upper and lower tract UC.
- Published
- 2020